AstraZeneca
AZN
$69.20
Share price
0.82%
Change (1 day)
3.10%
Change (1 year)
Categories
Revenue for AstraZeneca (AZN)
Revenue in 2022 (TTM): $44.35 B
According to AstraZeneca's latest financial reports the company's current revenue (TTM) is $44.35 B. In 2021 the company made a revenue of $37.41 B an increase over the years 2020 revenue that were of $26.61 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for AstraZeneca from 2001 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $44.35 B | 18.53% |
| 2021 | $37.41 B | 40.58% |
| 2020 | $26.61 B | 9.16% |
| 2019 | $24.38 B | 10.38% |
| 2018 | $22.09 B | -1.67% |
| 2017 | $22.46 B | -2.33% |
| 2016 | $23.00 B | -6.9% |
| 2015 | $24.70 B | -5.32% |
| 2014 | $26.09 B | 1.49% |
| 2013 | $25.71 B | -8.09% |
| 2012 | $27.97 B | -16.72% |
| 2011 | $33.59 B | 0.97% |
| 2010 | $33.26 B | 1.42% |
| 2009 | $32.80 B | 3.81% |
| 2008 | $31.60 B | 6.91% |
| 2007 | $29.55 B | 11.65% |
| 2006 | $26.47 B | 10.54% |
| 2005 | $23.95 B | 11.78% |
| 2004 | $21.42 B | 13.67% |
| 2003 | $18.84 B | 6.33% |
| 2002 | $17.72 B | -24.67% |
| 2001 | $23.53 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $94.94 B | 114.08% | 🇺🇸 USA |
 Novartis NVS | $51.82 B | 16.86% | 🇨🇭 Switzerland |
 Pfizer PFE | $100.33 B | 126.23% | 🇺🇸 USA |
 Abbott Laboratories ABT | $43.65 B | -1.57% | 🇺🇸 USA |
 Eli Lilly LLY | $28.54 B | -35.65% | 🇺🇸 USA |
 Sanofi SNY | $47.62 B | 7.39% | 🇫🇷 France |
 Biogen BIIB | $10.17 B | -77.06% | 🇺🇸 USA |
 Merck MRK | $59.28 B | 33.67% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $46.15 B | 4.08% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $38.94 B | -12.20% | 🇬🇧 UK |